12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Monday's pre-market session. Zynerba Pharmaceuticals, Taysha Gene Therapies, Virios Therapeutics, Nemaura Medical, Trxade Health, and Mainz Biomed saw gains, while BioXcel Therapeutics, Science 37 Hldgs, PHAXIAM Therapeutics, Fortrea Holdings, NovaBay Pharmaceuticals, and Valneva experienced losses. Q2 earnings reports were recently released for several of these companies.
August 14, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Taysha Gene Therapies stock rose 74.56% to $1.29.
The rise in Taysha Gene Therapies' stock price suggests positive investor sentiment, potentially due to recent company developments or market trends.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Zynerba Pharmaceuticals stock increased by 301.2% to $1.36 during Monday's pre-market session.
The significant increase in Zynerba Pharmaceuticals' stock price indicates positive investor sentiment, potentially due to recent company developments or market trends.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
BioXcel Therapeutics stock declined by 35.7% to $4.76 during Monday's pre-market session. The Q2 earnings report came out today.
The decline in BioXcel Therapeutics' stock price, coinciding with the release of its Q2 earnings report, suggests that the financial results may have been below market expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100